Why did the GSK share price top 2,000p today?

Investors welcomed strong GSK results, reaffirmation of the £40bn 2031 sales target, and guidance to lift the total dividend to 70p in 2026. That mix improved confidence in growth and cash returns. The move also drew passive and income flows as the FTSE 100 set a record, reinforcing buying interest.

What is GSK dividend 2026 guidance and is it sustainable?

Management flagged a total dividend of 70p in 2026. Current coverage looks reasonable, with a payout ratio near 50.7%, interest coverage around 11.5 times, and free cash flow yield about 7.6%. Sustainability still depends on execution, cash conversion, and product momentum, but today’s framework supports the income case.

Are the GSK results enough to make the stock a buy now?

The update improved visibility on growth and payouts, which is positive. Valuation is near 14.7 times trailing earnings, while our grade is B with a Hold suggestion and the Street skews cautious at 4 Hold and 3 Sell. Further evidence on pipeline delivery may be needed for a clear upgrade.

How did GSK’s move help the FTSE 100 record?

A sharp rise in a large-cap healthcare name adds significant index points, amplifying broader strength. As GSK rallied on results and dividend guidance, the FTSE 100 set a new record. That can attract additional passive and income-focused flows, supporting both the index and near-term sentiment in UK equities.

Global Market Insights

GSK Stock Today: February 04 – Shares Top 2,000p on Results, Dividend Lift

ByDanny Kontos February 4, 2026February 4, 2026

The GSK share price jumped above 2,000p on 4 February after robust GSK results, a reaffirmed £40bn 2031 sales target, and guidance to lift the total payout to 70p in 2026. The move helped the FTSE 100 set a record high, underscoring stronger earnings visibility and income appeal. With UK investors focused on dependable cash returns and defensible growth, we review what drove today’s rally, how the dividend path looks, and where the valuation sits after the surge.